Clinical trials
Recherche d’études cliniques
Recherchez uniquement dans les études cliniques enregistrées dans Biomedical Watch.
Études cliniques 3370
| Étude / NCT ⇅ | Molécule ⇅ | Maladie ⇅ | Phase ⇅ | Statut ⇅ | Résultat ⇅ | Sponsor ⇅ | Pays / centres ⇅ | Période ⇅ | Détail |
|---|---|---|---|---|---|---|---|---|---|
| NCT07217587 EPIC — Comparative Efficacy of Nipocalimab and Efgartigimod in Particip… |
Nipocalimab | Myasthénie | Phase 3 | RECRUITING | En attente / non publié | Janssen Research & Development, L… | United States, Israel, Switzerland · Advanced Neurolo… | 2026-01-05 → 2029-01-29 | Ouvrir |
| NCT07075627 A Study to Evaluate the Incidence of Clinically Suspicious Lambert-Eato… |
A Study to Evaluate the Incidence… | Myasthénie | À vérifier | WITHDRAWN | En attente / non publié | Addario Lung Cancer Medical Insti… | United States · Dana-Farber Cancer Institute, Boston,… | 2025-09 → 2026-12 | Ouvrir |
| NCT06259071 MuSK 1000 — MuSK Myasthenia 1000 Study |
MuSK 1000 — MuSK Myasthenia 1000 … | Myasthénie | À vérifier | RECRUITING | En attente / non publié | George Washington University | United States · George Washington University, Washing… | 2023-08-23 → 2027-12-31 | Ouvrir |
| NCT06298552 ADAPT SERON — A Phase 3 Study to Evaluate the Efficacy and Safety of Ef… |
Efgartigimod IV | Myasthénie | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | argenx | United States, Belgium, Canada, China, Cyprus, Czechi… | 2024-04-16 → 2028-06 | Ouvrir |
| NCT06688435 A Study to Evaluate the Safety and Preliminary Efficacy of SYS6020 CAR … |
SYS6020 injection | Myasthénie | Phase 1 | RECRUITING | En attente / non publié | CSPC ZhongQi Pharmaceutical Techn… | China · Qilu Hospital, Shandong University, Jinan, Ch… | 2025-03-04 → 2033-05-01 | Ouvrir |
| NCT07247279 Epidemiological Study of Treatment Approaches in AChR-Antibody Positive… |
Epidemiological Study of Treatmen… | Myasthénie | À vérifier | RECRUITING | En attente / non publié | AstraZeneca | Russia · Research Site, Kazan', Russia | Research Sit… | 2025-12-23 → 2029-12-31 | Ouvrir |
| NCT06517758 A Phase III Study to Investigate Efficacy, Safety and Tolerability of I… |
Iptacopan | Myasthénie | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Novartis Pharmaceuticals | United States, Argentina, Australia, Brazil, China, D… | 2024-07-31 → 2032-05-27 | Ouvrir |
| NCT07284420 ADAPT Forward 1 - ISA1 - a Study to Evaluate Empasiprubart IV as add-on… |
Efgartigimod IV | Myasthénie | Phase 2 | RECRUITING | En attente / non publié | argenx | United States, Belgium, Germany, Greece, Italy, Japan… | 2025-12-19 → 2028-03-07 | Ouvrir |
| NCT06463587 Efficacy and Safety of a New Formulation of Oral Cladribine Compared Wi… |
Cladribine Low Dose | Myasthénie | Phase 3 | RECRUITING | En attente / non publié | Merck Healthcare KGaA, Darmstadt,… | United States, Argentina, Australia, Belgium, Bulgari… | 2024-06-25 → 2030-11-12 | Ouvrir |
| NCT04225871 RAISE-XT — Open-Label Extension of Zilucoplan in Subjects With Generali… |
zilucoplan (RA101495) | Myasthénie | Phase 3 | COMPLETED | En attente / non publié | UCB Biopharma SRL | United States, Canada, France, Germany, Italy, Japan,… | 2019-12-23 → 2026-07-31 | Ouvrir |
| NCT07556120 Efficacy and Safety of HN2301 in Patients With Generalized Myasthenia G… |
HN2301 injection | Myasthénie | Phase 1 | NOT_YET_RECRUITING | En attente / non publié | Shenzhen MagicRNA Biotechnology C… | China · The First Affiliated Hospital of University o… | 2026-12-31 → 2028-12-31 | Ouvrir |
| NCT07761026 AXIS MG Patient Registry |
AXIS MG Patient Registry | Myasthénie | À vérifier | RECRUITING | En attente / non publié | Autoimmune Neurology Alliance | United States · Alira Health - Virtual/Remote Site - … | 2026-03-19 → 2036-03 | Ouvrir |
| NCT06564974 DMD-001 SUMMIT — Registry Study to Observe Long-term Safety of Vamorolo… |
Vamorolone | Myopathies | À vérifier | RECRUITING | En attente / non publié | Catalyst Pharmaceuticals, Inc. | United States, Puerto Rico · Arkansas Childrens Hospi… | 2024-09-25 → 2032-02 | Ouvrir |
| NCT07172971 CHERISH — Sodium/Glucose Cotransporter-2 Inhibitors (SGLT2i) Therapy in… |
SGLT-2 inhibitor | Myopathies | Phase 1 | RECRUITING | En attente / non publié | Vanderbilt University Medical Cen… | United States · Vanderbilt University Medical Center,… | 2026-07-01 → 2028-02-01 | Ouvrir |
| NCT04800874 Study of BBP-418 in Patients With LGMD2I |
BBP-418 | Myopathies | Phase 2 | ACTIVE_NOT_RECRUITING | En attente / non publié | ML Bio Solutions, Inc. | United States · Virginia Commonwealth University, Ric… | 2021-02-18 → 2026-11-01 | Ouvrir |
| NCT04281485 Study to Evaluate the Safety and Efficacy of PF-06939926 for the Treatm… |
PF-06939926 | Myopathies | Phase 3 | ACTIVE_NOT_RECRUITING | En attente / non publié | Pfizer | United States, Australia, Belgium, Canada, France, Ge… | 2020-11-05 → 2039-04-15 | Ouvrir |
| NCT06998134 Toward Ubiquitous Lower Limb Exoskeleton Use in Children and Young Adul… |
Extension assist knee ankle foot … | Myopathies | À vérifier | RECRUITING | En attente / non publié | National Institutes of Health Cli… | United States · National Institutes of Health Clinica… | 2026-06-23 → 2028-08-18 | Ouvrir |
| NCT07008469 HARBOR-OLE — Global Open-Label Extension Study of Del-desiran for the T… |
Del-desiran (AOC 1001) | Myopathies | Phase 3 | ENROLLING_BY_INVITATION | En attente / non publié | Avidity Biosciences, Inc. | United States, Canada, Denmark, France, Germany, Ital… | 2025-06-26 → 2030-10 | Ouvrir |
| NCT07573631 An Open-Label Extension Study to Evaluate the Long-term Safety and Effi… |
BMN 351 | Myopathies | Phase 2 | ENROLLING_BY_INVITATION | En attente / non publié | BioMarin Pharmaceutical | Italy, Netherlands, Spain, Turkey (Türkiye), United K… | 2026-04-20 → 2031-12 | Ouvrir |
| NCT05933057 ULYSSES — Efficacy, Safety and Tolerability of Givinostat in Non-ambula… |
Givinostat | Myopathies | Phase 3 | RECRUITING | En attente / non publié | Italfarmaco | Belgium, Canada, Czechia, France, Germany, Italy, Net… | 2024-02-19 → 2028-02 | Ouvrir |
| NCT04972604 CDLink — CureDuchenne Link®: A Resource for Research |
CDLink — CureDuchenne Link®: A Re… | Myopathies | À vérifier | COMPLETED | En attente / non publié | CureDuchenne | United States · Arkansas Children's Hospital, Little … | 2021-07-09 → 2025-12-12 | Ouvrir |
| NCT07038200 FORTITUDE-3 — A Study to Evaluate Del-brax (Also Referred to as AOC 102… |
AOC-1020 | Myopathies | Phase 3 | RECRUITING | En attente / non publié | Avidity Biosciences, Inc. | United States, Canada, Denmark, France, Germany, Ital… | 2025-06-10 → 2028-07 | Ouvrir |
| NCT06809049 Music Intervention for Brain-Heart Disease in Myotonic Dystrophy Type 1… |
Music Intervention for Brain-Hear… | Myopathies | Non applicable | ACTIVE_NOT_RECRUITING | En attente / non publié | Hanns Lochmuller | Canada · Children's Hospital of Eastern Ontario, Otta… | 2025-03-25 → 2026-10 | Ouvrir |
| NCT07674758 Modeling Mortality in Duchenne Muscular Dystrophy Cardiomyopathy: Ident… |
Modeling Mortality in Duchenne Mu… | Myopathies | À vérifier | RECRUITING | En attente / non publié | Vanderbilt University Medical Cen… | United States · Children's Hospital of Richmond at VC… | 2025-01-06 → 2029-02-01 | Ouvrir |
| NCT07732439 Track-DM — An Ambispective Natural History Study in Myotonic Dystrophy … |
Track-DM — An Ambispective Natura… | Myopathies | À vérifier | NOT_YET_RECRUITING | En attente / non publié | Lupin Ltd. | France · Centre de référence des maladies neuromuscul… | 2026-08-03 → 2029-09 | Ouvrir |